Global Senolytic Drugs Market By Type, By Therapeutic Application (Cardiovascular Diseases, Neurological Disorders, Osteoarthritis, and Others), Age Group, Mode of Administration, By Distribution Channel - Global Industry Outlook, Key Companies (Unity Biotechnology, Cleara Biotech, Gero LLC and others), Trends and Forecast 2024-2033 Market Overview The Global Senolytic Drugs Market is projected to reach USD 42.5 million in 2024 and grow at a compound annual growth rate of 35.8% from there until 2033 to reach a value of USD 667.6 million
High is for active people with moderate strength training and an average body fat percentage
Paolicchi A, Pezzini A, Saviozzi M, Piaggi S, Andreuccetti M, Chieli E, Malvaldi G, Casini AF
CELLF 2.0 contains the anti-oxidant, anti-aging and mitochondrial activating ingredients: Glutathione, PQQ and CoQ10 that are clinically proven to increase lifespan, cognitive function and energy production respectively
Contact us today to schedule your consultation
The company's proprietary NanoPortal drug implant platform technology will be applied for the first time in this clinical study which focuses on treating obese and overweight individuals